Orange Health Labs has raised $12 million in funding, with Amazon Smbhav Venture Fund among the investors, including Accel, General Catalyst, Bertelsmann India Investments, and Y Combinator. Furthermore, this round brings the total funds raised by the company to $47 million.
The company plans to use the funds to enhance its technology, scale its operations, and drive innovation in diagnostics to meet the growing demand for efficient and accessible healthcare solutions in India.
The company plans to use the funds to expand its products, grow its team, and drive innovation in diagnostics. Known for its at-home sample collection within an hour, extended operating hours, and six-hour report delivery, Orange Health Labs focuses on convenience and speed.
Founded in December 2020 by Dhruv Gupta and TarunBhambra, Orange Health has established itself as an on-demand diagnostic leader, providing at-home sample collection services in cities such as Bengaluru, Gurugram, Delhi, Noida, and Ghaziabad. With a customer base exceeding 1 million and partnerships with over 1,000 clinics, the firm claims a 3x growth over the last two years and projects 100% growth this year.
“Today’s consumers want things available to them at their convenience, and quick commerce is the biggest example of this in the last four or five years. While you could wait 20 minutes for your chips, speed matters more when you’re sick,” cofounder Dhruv Gupta said.
“This process typically takes 18 hours in a traditional lab. Over time, we have streamlined the whole process to bring it down to six hours,” he added.
In June 2022, Orange Health secured $25 million in its Series B round, spearheaded by General Catalyst and Bertelsmann India Investments. Three months later, the company launched its first employee stock option plan and equity buyback program worth $1 million, highlighting its commitment to employee growth.
Currently operating in four metro cities, the company aims to strengthen its presence before expanding to other tier-1 cities.
Gupta said these four metro cities account for 25% of the diagnostic market. “Our primary focus right now, rather than pursuing wide geographic expansion, is to serve customers in these cities and build greater dominance. Probably over the next year or so, we will expand to the next set of metros and tier 1 cities, and then beyond that,” he added.
Additionally, Orange Health recently surpassed an annual revenue run rate of ₹100 crore and achieved profitability in Bengaluru. Orange Health operates six labs and is now poised to accelerate its innovation journey. Amazon’s $250 million Smbhav Venture Fund, which has previously backed startups like The Good Glamm Group and Smallcase, strengthens its confidence in the transformative potential of Indian startups.
Commenting on the investment, Abhijeet Muzumdar, vice president corporate development and head of Amazon Smbhav Venture Fund, said, “Dhruv, Tarun and their team at Orange Health Labs have created a robust diagnostics service and we are excited to back them for the next phase of their growth.”
